Company / R&D per Share
Traws Pharma, Inc. R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.52
FY2024
5-year range
$0.14 / $3.52
FY2020-FY2024
Trend
+545.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +546% YoY in FY2024, a notable deviation from the 9-year average annual change of +262%.
Based on SEC 10-K filings.
3.52 in FY2024 with a 5-year CAGR of +3.4%.
Improved from $0.35 to $3.52 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +34.2%
- 5-Year CAGR
- +3.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, r&d per share increased 545.6% year-over-year.
- Peak r&d per share was recorded in FY2018.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.52 | +545.6% |
| FY2023 | $0.55 | +56.1% |
| FY2022 | $0.35 | -76.0% |
| FY2021 | $1.46 | +941.2% |
| FY2020 | $0.14 | -95.3% |
| FY2019 | $2.98 | -88.8% |
| FY2018 | $26.63 | +796.7% |
| FY2017 | $2.97 | -70.8% |
| FY2016 | $10.17 | +346.5% |
| FY2015 | $2.28 | -7.3% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026